Avalon GloboCare Stock Set to Reverse Split on Monday, October 28th (NASDAQ:ALBT)

Avalon GloboCare Corp. (NASDAQ:ALBT) shares are scheduled to reverse split on the morning of Monday, October 28th. The 1-15 reverse split was announced on Thursday, October 24th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, October 25th.

Avalon GloboCare Stock Performance

Shares of ALBT stock remained flat at $0.20 on Thursday. The stock had a trading volume of 2,564,404 shares, compared to its average volume of 2,414,625. Avalon GloboCare has a 12 month low of $0.16 and a 12 month high of $1.44. The company’s fifty day moving average price is $0.25 and its 200-day moving average price is $0.34. The stock has a market cap of $2.25 million, a price-to-earnings ratio of -0.14 and a beta of 0.31.

Avalon GloboCare (NASDAQ:ALBT) last announced its earnings results on Monday, August 19th. The company reported ($0.19) EPS for the quarter. The company had revenue of $0.33 million during the quarter.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.